The latest situation of research and development of COVID-19 enhanced needle Zhang Wenhong revealed the specific time of listing

An aggressive COVID-19 epidemic has become the most serious global public health emergency since the end of World War II. So far, the number of confirmed cases worldwide has exceeded 5 million and the number of deaths has exceeded 300000. In the face of the rampant epidemic, everyone places their hopes on COVID-19 vaccine. What is the latest progress in the research and development of COVID-19 vaccine? When can it be launched? Time to market of COVID-19 vaccine

Now many countries are accelerating the research and development of COVID-19 vaccine, while China is leading the research and development of COVID-19 vaccine, and it is proposed that COVID-19 vaccine will be used as a global public product after its research and development is completed and put into use. The World Health Organization claims that over 120 candidate vaccines are currently under development, and the actual number is certainly even higher, some of which are undergoing clinical evaluation.

There is no shortcut for the research and development of COVID-19 vaccine. It must be carried out in accordance with safe and effective standards, and no step can be skipped. Out of the 10 vaccines undergoing clinical trials globally, 5 are in China. Currently, one recombinant adenovirus vector vaccine and four inactivated vaccine projects have been approved by the National Medical Products Administration for clinical trials, but there have been no reports of significant adverse reactions. If everything goes smoothly, the above projects will gradually complete phase II clinical trials in July this year. As for when the COVID-19 vaccine will be launched, Zhang Wenhong said that the victory over the epidemic will ultimately depend on the vaccine. It is expected that the COVID-19 vaccine will be launched as soon as March to June 2021, when everyone can resume normal life.